January 05, 2015
Moderna Closes $450 Million Financing to Support Growth of Messenger RNA Therapeutics™ Platform across Diverse Therapeutic Areas
October 16, 2014
Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics™
July 01, 2014
Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido
June 17, 2014
Moderna Named to CNBC Disruptor 50 List
June 12, 2014
Moderna Announces Expansion to New Facility in Kendall Square
May 21, 2014
Moderna Forms Technology Advisory Board to Provide Expertise for the Company’s GMP Manufacturing Strategy
March 06, 2014
Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer
February 19, 2014
Massachusetts Life Sciences Center Awards Tax Incentives to 33 Companies (PDF File)
January 14, 2014
Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment
January 13, 2014
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics™ for Rare Diseases

Pages